Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

about

Development and Validation of an Assay to Analyze Atazanavir in Human Hair Via Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

P2860

Q47724822-3D8F0C10-0050-438C-A194-124F0E1A4D23

P2860

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

Item

http://www.wikidata.org/entity/Q47556636

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@en

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@nl

type

Item

label

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@en

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@nl

prefLabel

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@en

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@nl

P1476

Comparing pharmacologic measur ...... prophylaxis randomized trial.

@en

P2093

Albert Y Liu

http://www.w3.org/2001/XMLSchema#string

Eric Vittinghoff

http://www.w3.org/2001/XMLSchema#string

Kata Chillag

http://www.w3.org/2001/XMLSchema#string

Monica Gandhi

http://www.w3.org/2001/XMLSchema#string

Peter Bacchetti

http://www.w3.org/2001/XMLSchema#string

Peter L Anderson

http://www.w3.org/2001/XMLSchema#string

Robert Grant

http://www.w3.org/2001/XMLSchema#string

Ruth M Greenblatt

http://www.w3.org/2001/XMLSchema#string

Ryan Wiegand

http://www.w3.org/2001/XMLSchema#string

Yong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)

Preexposure prophylaxis for HIV infection among African women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

P304

e0190118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0190118

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sanjiv M Baxi

Susan Buchbinder

P577

2018-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29315307

http://www.w3.org/2001/XMLSchema#string

P932

5760024

http://www.w3.org/2001/XMLSchema#string

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

about

P2860

P2860

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932